UroGen Pharma Ltd (URGN) financials · rev $109.8M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
UroGen Pharma Ltd (URGN) rev $109.8M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $109.8M | $90.4M |
| Cost of Revenue | $12.4M | N/A |
| Gross Profit | $97.3M | N/A |
| Operating Income | -$124.9M | N/A |
| Net Income | -$153.5M | -$126.9M |
| EPS (Diluted) | -$3.19 | -$2.96 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $200.5M | $285.7M |
| Current Assets | $186.0M | $276.1M |
| Cash & Equivalents | $110.7M | $172.0M |
| Inventory | $16.5M | $9.23M |
| PP&E | $637.0K | $655.0K |
| Total Liabilities | $305.9M | $294.5M |
| Current Liabilities | $46.4M | $45.9M |
| Long-term Debt | $122.2M | $121.7M |
| Total Debt | $122.2M† | $121.7M† |
| Shareholders' Equity | -$105.5M | -$8.80M |
| Retained Earnings | -$959.7M | -$806.2M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$162.4M | -$96.8M |
| CapEx | $289.0K | $295.0K |
| Investing Cash Flow | $61.6M | -$20.6M |
| Financing Cash Flow | $39.9M | $194.6M |
| Net Change in Cash | -$61.0M | $77.2M |
| Free Cash Flow | -$162.7M | -$97.1M |
FAQ
What is URGN P/E and revenue?
UroGen Pharma Ltd (URGN) rev $109.8M.
What is URGN revenue?
UroGen Pharma Ltd last cached revenue is $109.8M (FY2025).
Is URGN profitable?
UroGen Pharma Ltd last cached net income is -$153.5M (FY2025).
What are URGN total assets?
UroGen Pharma Ltd last cached total assets are $200.5M (FY2025).
What is URGN free cash flow?
UroGen Pharma Ltd last cached free cash flow is -$162.7M (FY2025).
Not investment advice. Cached statements, not a live tape.